| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/15/2013 | CN103099837A Wild chrysanthemum juice and preparation method thereof |
| 05/15/2013 | CN103099828A 维生素c泡腾片 Effervescent vitamin c |
| 05/15/2013 | CN103099826A Method for extracting taxusflavone from taxus chinensis leaves |
| 05/15/2013 | CN103099823A Anti-hepatitis B pharmaceutical composition and its preparation method and use |
| 05/15/2013 | CN103099814A Chick bacterial disease preventing and treating composition |
| 05/15/2013 | CN103099813A Preparation method and applications of deoxymononucleotide natrium-containing drug composition and preparation thereof |
| 05/15/2013 | CN103099812A Medicine for treating porcine reproductive and respiratory syndrome and preparation method thereof |
| 05/15/2013 | CN103099811A Chicken coccocidiosis preventing and treating composition |
| 05/15/2013 | CN103099808A Application of para-di-n-propylamine sulfonyl benzoic acid to veterinary medicines |
| 05/15/2013 | CN103099807A Compound zinc gluconate and ibuprofen oral-administration composition for covering bitter taste and improving ibuprofen dissolution |
| 05/15/2013 | CN103099792A Preparation method of IV crystal linezolid tablets having high drug loading capacity and capable of quickly dissolving |
| 05/15/2013 | CN103099788A Traditional Chinese medicine composite decoration from powder, preparation and decoction methods and dosage relation thereof |
| 05/15/2013 | CN103099786A Preparation method of micro/nanofiber sustained release preparation |
| 05/15/2013 | CN103099777A Bio-enzyme hydrogel taking porous calcium carbonate as carrier and preparation method of bio-enzyme hydrogel |
| 05/15/2013 | CN102872132B Application of Houttuynoid D in anti-helicobacter pylori drug |
| 05/15/2013 | CN102872091B Application of Houttuynoid E in anti-tubercle bacillus medicine |
| 05/15/2013 | CN102861083B Application of Houttuynoid B in anti-human fungi medicine |
| 05/15/2013 | CN102631632B Preparation method of traditional Chinese medicine lotion for treating blood stasis type pustule on sole |
| 05/15/2013 | CN102488715B Natural oral cavity disinfectant and preparation method thereof |
| 05/15/2013 | CN102397481B Medicinal preparation for wind dispelling and heat dissipating and preparation method thereof |
| 05/15/2013 | CN102380070B External Chinese medicine for treating tinea pedis |
| 05/15/2013 | CN102379879B Liranaftate and mometasone furoate containing locally applied compound pharmaceutical composition |
| 05/15/2013 | CN102349990B Traditional Chinese medicine for treating hepatitis B |
| 05/15/2013 | CN102319413B Medicine for treating influenza |
| 05/15/2013 | CN102309725B Traditional Chinese medicine preparation for treating hepatitis B cirrhosis and preparation method |
| 05/15/2013 | CN102302519B Propolis nano-emulsion and preparation method thereof |
| 05/15/2013 | CN102293848B Foot massage preparation for treating cold |
| 05/15/2013 | CN102266339B Synergist for improving resistance of ethambutol to mycobacterium |
| 05/15/2013 | CN102258571B Formula of children' s antipyretic granule by using radix bupleuri and cassia twig, and its preparation method |
| 05/15/2013 | CN102225065B Parcetamol pseudoephedrine hydrochloride and dextromethorphan hydrochloride capsule and preparation method thereof |
| 05/15/2013 | CN102167734B Recombinant mutant tenebrio molitor antibacterial peptide and its gene and application |
| 05/15/2013 | CN102048751B Medicine for treating venereal disease |
| 05/15/2013 | CN102002054B Pyrazole type compound and preparation method and application thereof |
| 05/15/2013 | CN101953834B Formula and preparation process of aztreonam for injection |
| 05/15/2013 | CN101830896B Organic acid salt of optical isomer of penehyclidine |
| 05/15/2013 | CN101773511B Compound topical combination drug for treatment of acne and preparation method thereof |
| 05/15/2013 | CN101744841B Bifidobacterium for treating inflammatory disease |
| 05/15/2013 | CN101627056B Y-type polyethylene glycol modified g-csf and preparation method and use thereof |
| 05/15/2013 | CN101531679B Method for preparing phosphonyl methoxyl nucleotide analogue |
| 05/15/2013 | CN101392229B Engineering strain for directly producing gernebcin and use thereof |
| 05/15/2013 | CN101313061B Method of expanding double negative T cells |
| 05/15/2013 | CN101255195B Deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection |
| 05/14/2013 | US8440794 Peptide sequences, their branched form and use thereof for antimicrobial applications |
| 05/14/2013 | US8440792 Antimicrobial peptides and derived metapeptides |
| 05/14/2013 | US8440696 Method of using diketopiperazines and composition containing them |
| 05/14/2013 | US8440668 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of type 2 diabetes |
| 05/14/2013 | US8440233 Compositions against rotavirus infection and processes for producing the same |
| 05/14/2013 | US8440205 Streptococcal C5A peptidase vaccine |
| 05/14/2013 | US8440189 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 05/14/2013 | CA2694495C Capsule composition for use as immunogen against campylobacter jejuni |
| 05/14/2013 | CA2532965C 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| 05/14/2013 | CA2509827C A set of oligo-nucleotides against hiv infection and its application in the prevention and treatment of acquired immune deficiency syndrome |
| 05/14/2013 | CA2497572C Akt inhibitors, pharmaceutical compositions, and uses thereof |
| 05/14/2013 | CA2465753C Orodispersible tablet having high homogeneity and the preparation method thereof |
| 05/14/2013 | CA2455915C Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 05/14/2013 | CA2453937C Antigenic polypeptides |
| 05/14/2013 | CA2441562C Short bioactive peptides and methods for their use |
| 05/14/2013 | CA2376698C Streptogramin derivatives, preparation and compositions containing them |
| 05/14/2013 | CA2362606C Therapeutic antimicrobial compositions |
| 05/14/2013 | CA2260079C Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications |
| 05/10/2013 | WO2013067267A1 Rod -like hepatitis c virus inhibitors containing the fragement {2- [4- (bi phenyl - 4 - yl) - 1h - imidazo - 2 - yl] pyrrolidine - 1 - carbonlymethyl} amine |
| 05/10/2013 | WO2013067260A1 Bicyclic piperazine compounds |
| 05/10/2013 | WO2013066876A1 Anti-glucosaminidase passive immunization for staphylococcus aureus infections |
| 05/10/2013 | WO2013066748A1 Methods and compositions for treating hepatitis c virus |
| 05/10/2013 | WO2013065690A1 Prophylactic or therapeutic agent for virus infectious disease |
| 05/10/2013 | WO2013065065A1 Optically active fluconazole analogues containing thiophenes as antifungal agents |
| 05/10/2013 | WO2013064818A1 Aptamers |
| 05/10/2013 | WO2013064672A2 Oxazaphosphorines dosed one time for treating diseases |
| 05/10/2013 | WO2013064538A1 Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection |
| 05/10/2013 | WO2013063755A1 Oligopeptide for treating liver fibrosis and/or hepatitis b and/or improving liver function |
| 05/10/2013 | WO2013063695A1 Compositions and methods for preventing and treating oral diseases |
| 05/10/2013 | WO2013039428A3 Quinoline derivatives and method for producing and using same |
| 05/10/2013 | WO2013036827A3 Fungal-specific metalloproteases and uses thereof |
| 05/10/2013 | WO2013010018A3 Compositions and methods for inhibiting proteases |
| 05/10/2013 | WO2012177756A3 Non-leaching antimicrobial wound dressing |
| 05/10/2013 | WO2012112548A3 Firmocidin, an antimicrobial molecule produced by staphylococcus epidermidis |
| 05/10/2013 | CA2855641A1 Optically active fluconazole analogues containing thiophenes as antifungal agents |
| 05/10/2013 | CA2854129A1 Compositions useful for the treatment of viral diseases |
| 05/10/2013 | CA2853943A1 Anti-glucosaminidase passive immunization for staphylococcus aureus infections |
| 05/10/2013 | CA2853857A1 Compositions and methods for preventing and treating oral diseases |
| 05/10/2013 | CA2853495A1 Methods and compositions for treating hepatitis c virus |
| 05/10/2013 | CA2853006A1 Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection |
| 05/10/2013 | CA2852964A1 Bicyclic piperazine compounds |
| 05/10/2013 | CA2852700A1 Rod-like hepatitis c virus inhibitors containing the fragment {2-[4-(biphenyl-4-yl)-1h-imidazo-2-yl]pyrrolidine-1-carbonlymethyl}amine |
| 05/09/2013 | US20130116268 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 05/09/2013 | US20130116237 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists |
| 05/09/2013 | US20130116219 Antimicrobial carboline compounds |
| 05/09/2013 | US20130115265 Drug delivery system |
| 05/09/2013 | US20130115224 METHODS OF TREATING DISORDERS USING HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 05/09/2013 | US20130115194 Hepatitis c virus inhibitors |
| 05/09/2013 | US20130115191 T cell receptor fusions and conjugates and methods of use thereof |
| 05/08/2013 | EP2589604A1 Truncated l1 protein of human papillomavirus type 52 |
| 05/08/2013 | EP2589595A1 Agent for treating hcv infection |
| 05/08/2013 | EP2588477A1 Quinolines as pi3k inhibitors |
| 05/08/2013 | EP2588470A1 Riminophenazines with 2-(heteroaryl)amino substituents and their anti-microbial activity |
| 05/08/2013 | EP2588464A1 Benzofuran derivatives for the treatment of hepatits c |
| 05/08/2013 | EP2588455A1 2 -quinolinyl- acetic acid derivatives as hiv antiviral compounds |
| 05/08/2013 | EP2588450A1 Napht- 2 -ylacetic acid derivatives to treat aids |
| 05/08/2013 | EP2588135A2 Nanoemulsion vaccines |
| 05/08/2013 | EP2588120A2 Compositions and methods related to protein a (spa) variants |